IMIC, Inc. is a clinical research site located in Miami, Florida, United States 33176.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
IMIC, Inc. has participated in 7 clinical trials with 2 currently active.
Therapeutic areas: Alzheimer Disease, COVID-19, SARS-COV-2 Infection.
Sponsors: Eli Lilly and Company, BioNTech SE, Bellerophon Pulse Technologies.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
IMIC, Inc. has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
IMIC, Inc. has 7 clinical trials on record, with 2 currently active. Their work covers Alzheimer Disease, COVID-19, SARS-COV-2 Infection.
Yes — IMIC, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.